Lubowel 24 Soft Gelatin Capsule contains Lubiprostone 24 mcg, a chloride channel activator indicated for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adult patients. Lubiprostone acts locally on the apical membrane of the gastrointestinal epithelial cells by selectively activating type-2 chloride channels (ClC-2), leading to increased intestinal fluid secretion. This mechanism facilitates stool passage and improves bowel movement frequency and consistency without altering serum electrolyte levels. Lubowel 24 is administered orally, typically twice daily with food and water to minimize gastrointestinal side effects. Clinical studies have demonstrated its efficacy in reducing constipation symptoms, including straining, incomplete evacuation, and abdominal discomfort. The safety profile of Lubowel 24 is generally favorable; common adverse effects may include nausea, diarrhea, abdominal pain, and headache, which are usually mild to moderate in intensity. It is contraindicated in patients with known hypersensitivity to Lubiprostone and should be used cautiously in individuals with severe diarrhea or gastrointestinal obstruction. Lubowel 24 Soft Gelatin Capsule provides a targeted therapeutic option for patients suffering from chronic constipation and IBS-C, improving quality of life through enhanced bowel function and symptom relief.